An E-platform for Learners

Day: August 4, 2025

Merck’s Winrevair™ Gains FDA Priority Review Following Stellar ZENITH Trial Data

Merck’s Winrevair™ Gains FDA Priority Review Following Stellar ZENITH Trial Data

Pharm'Up

Merck has revealed that the U.S. Food and Drug Administration (FDA) has accepted and granted priority review...

Novartis Reveals Phase III GCAptAIN Trial Outcomes: Cosentyx Misses Primary Target for Giant Cell Arteritis

Novartis Reveals Phase III GCAptAIN Trial Outcomes: Cosentyx Misses Primary Target for Giant Cell Arteritis

Pharm'Up

Novartis has disclosed the preliminary findings from its Phase III GCAptAIN study, assessing Cosentyx® (secukinumab) for the...

Lupin Introduces Ipratropium Bromide Nasal Spray in the U.S. Market

Lupin Introduces Ipratropium Bromide Nasal Spray in the U.S. Market

Pharm'Up

Global pharmaceutical leader Lupin Limited has unveiled the launch of Ipratropium Bromide Nasal Solution (Nasal Spray) in...

Biocon Biologics Gains UK Approval for Denosumab Biosimilars

Biocon Biologics Gains UK Approval for Denosumab Biosimilars

Pharm'Up

Biocon Biologics Ltd. (BBL), a leading global biosimilars company and subsidiary of Biocon Ltd., has received marketing...